{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:46:17Z","timestamp":1789055177023,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10787-023-01354-2","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T17:01:58Z","timestamp":1697475718000},"page":"3317-3325","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regression"],"prefix":"10.1007","volume":"31","author":[{"given":"Arto Yuwono","family":"Soeroto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendarsyah","family":"Suryadinata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo Audi","family":"Yanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1748-9776","authenticated-orcid":false,"given":"Timotius Ivan","family":"Hariyanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"issue":"5","key":"1354_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5501\/wjv.v9.i5.67","volume":"9","author":"A Dominari","year":"2020","unstructured":"Dominari A, Hathaway Iii D, Pandav K, Matos W, Biswas S, Reddy G et al (2020) Thymosin alpha 1: a comprehensive review of the literature. World J Virol 9(5):67\u201378. https:\/\/doi.org\/10.5501\/wjv.v9.i5.67","journal-title":"World J Virol"},{"issue":"7414","key":"1354_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"issue":"3","key":"1354_CR3","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/jmv.26698","volume":"93","author":"T Ivan Hariyanto","year":"2021","unstructured":"Ivan Hariyanto T, Kurniawan A (2021) Tocilizumab administration is associated with the reduction in biomarkers of coronavirus disease 2019 infection. J Med Virol 93(3):1832\u20131836. https:\/\/doi.org\/10.1002\/jmv.26698","journal-title":"J Med Virol"},{"key":"1354_CR4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.bioorg.2019.04.003","volume":"87","author":"J Kharazmi-Khorassani","year":"2019","unstructured":"Kharazmi-Khorassani J, Asoodeh A, Tanzadehpanah H (2019) Antioxidant and angiotensin-converting enzyme (ACE) inhibitory activity of thymosin alpha-1 (Th\u03b11) peptide. Bioorg Chem 87:743\u2013752. https:\/\/doi.org\/10.1016\/j.bioorg.2019.04.003","journal-title":"Bioorg Chem"},{"issue":"11","key":"1354_CR6","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/j.peptides.2010.07.026","volume":"31","author":"J Li","year":"2010","unstructured":"Li J, Liu CH, Wang FS (2010) Thymosin alpha 1: biological activities, applications and genetic engineering production. Peptides 31(11):2151\u20132158. https:\/\/doi.org\/10.1016\/j.peptides.2010.07.026","journal-title":"Peptides"},{"key":"1354_CR7","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-123265\/v1","author":"Y Li","year":"2020","unstructured":"Li Y, Li J, Ke J, Cheng S, Zhu L, Shen L (2020) Higher survival rate associated with thymosin alpha 1 use in critical COVID-19: a retrospective multicenter cohort study. Res Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-123265\/v1","journal-title":"Res Sq"},{"issue":"3","key":"1354_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/14787210.2021.1982695","volume":"20","author":"RY Limen","year":"2022","unstructured":"Limen RY, Sedono R, Sugiarto A, Hariyanto TI (2022) Janus kinase (JAK)-inhibitors and coronavirus disease 2019 (COVID-19) outcomes: a systematic review and meta-analysis. Expert Rev Anti Infect Ther 20(3):425\u2013434. https:\/\/doi.org\/10.1080\/14787210.2021.1982695","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"16","key":"1354_CR9","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1093\/cid\/ciaa630","volume":"71","author":"Y Liu","year":"2020","unstructured":"Liu Y, Pan Y, Hu Z, Wu M, Wang C, Feng Z et al (2020) Thymosin alpha 1 reduces the mortality of severe coronavirus disease 2019 by restoration of lymphocytopenia and reversion of exhausted T cells. Clin Infect Dis 71(16):2150\u20132157. https:\/\/doi.org\/10.1093\/cid\/ciaa630","journal-title":"Clin Infect Dis"},{"issue":"12","key":"1354_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.673693","volume":"2","author":"J Liu","year":"2021","unstructured":"Liu J, Shen Y, Wen Z, Xu Q, Wu Z, Feng H et al (2021) Efficacy of thymosin alpha 1 in the treatment of COVID-19: a multicenter cohort study. Front Immunol 2(12):673693. https:\/\/doi.org\/10.3389\/fimmu.2021.673693","journal-title":"Front Immunol"},{"key":"1354_CR11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ajem.2021.04.043","volume":"53","author":"T Liu","year":"2022","unstructured":"Liu T, Liu S, Li T, Zhang J (2022) Thymosin a1 use is not associated with reduced COVID-19 mortality. Am J Emerg Med 53:252\u2013253. https:\/\/doi.org\/10.1016\/j.ajem.2021.04.043","journal-title":"Am J Emerg Med"},{"issue":"6","key":"1354_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2147\/CLEP.S66677","volume":"10","author":"AV Margulis","year":"2014","unstructured":"Margulis AV, Pladevall M, Riera-Guardia N, Varas-Lorenzo C, Hazell L, Berkman ND et al (2014) Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle\u2013Ottawa scale and the RTI item bank. Clin Epidemiol 10(6):359\u2013368. https:\/\/doi.org\/10.2147\/CLEP.S66677","journal-title":"Clin Epidemiol"},{"issue":"1","key":"1354_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa588","volume":"8","author":"C Matteucci","year":"2020","unstructured":"Matteucci C, Minutolo A, Balestrieri E, Petrone V, Fanelli M, Malagnino V et al (2020) Thymosin alpha 1 mitigates cytokine storm in blood cells from coronavirus disease 2019 patients. Open Forum Infect Dis 8(1):ofaa588. https:\/\/doi.org\/10.1093\/ofid\/ofaa588","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"1354_CR14","first-page":"11870","volume":"9","author":"H Mustafa","year":"2022","unstructured":"Mustafa H, Hamza A, Shah NN, Samreen S, Din W (2022) Evaluation of role of thymosin alpha 1 in moderate to severe COVID-19 patients: a retrospective study. Eur J Mol Clin Med 9(3):11870\u201311876","journal-title":"Eur J Mol Clin Med"},{"issue":"372","key":"1354_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"29","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 29(372):n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"1354_CR16","doi-asserted-by":"publisher","first-page":"jiac362","DOI":"10.1093\/infdis\/jiac362","volume":"3","author":"F Shehadeh","year":"2022","unstructured":"Shehadeh F, Benitez G, Mylona EK, Tran QL, Tsikala-Vafea M, Atalla E et al (2022) A pilot trial of thymalfasin (T\u03b11) to treat hospitalized patients with hypoxemia and lymphocytopenia due to COVID-19 infection. J Infect Dis 3:jiac362. https:\/\/doi.org\/10.1093\/infdis\/jiac362","journal-title":"J Infect Dis"},{"issue":"8","key":"1354_CR17","doi-asserted-by":"publisher","first-page":"913","DOI":"10.5005\/jp-journals-10071-24298","volume":"26","author":"A Shetty","year":"2022","unstructured":"Shetty A, Chandrakant NS, Darnule RA, Manjunath BG, Sathe P (2022) A double-blind multicenter two-arm randomized placebo-controlled phase-III clinical study to evaluate the effectiveness and safety of thymosin \u03b11 as an add-on treatment to existing standard of care treatment in moderate-to-severe COVID-19 patients. Indian J Crit Care Med 26(8):913\u2013919. https:\/\/doi.org\/10.5005\/jp-journals-10071-24298","journal-title":"Indian J Crit Care Med"},{"issue":"366","key":"1354_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 28(366):l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"issue":"15","key":"1354_CR19","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283(15):2008\u20132012. https:\/\/doi.org\/10.1001\/jama.283.15.2008","journal-title":"JAMA"},{"key":"1354_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107143","volume":"90","author":"Q Sun","year":"2021","unstructured":"Sun Q, Xie J, Zheng R, Li X, Chen H, Tong Z et al (2021) The effect of thymosin \u03b11 on mortality of critical COVID-19 patients: a multicenter retrospective study. Int Immunopharmacol 90:107143. https:\/\/doi.org\/10.1016\/j.intimp.2020.107143","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"1354_CR21","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.3390\/molecules28083539","volume":"28","author":"N Tao","year":"2023","unstructured":"Tao N, Xu X, Ying Y, Hu S, Sun Q, Lv G et al (2023) Thymosin \u03b11 and its role in viral infectious diseases: the mechanism and clinical application. Molecules 28(8):3539. https:\/\/doi.org\/10.3390\/molecules28083539","journal-title":"Molecules"},{"issue":"13","key":"1354_CR22","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1002\/sim.1461","volume":"22","author":"N Terrin","year":"2003","unstructured":"Terrin N, Schmid CH, Lau J, Olkin I (2003) Adjusting for publication bias in the presence of heterogeneity. Stat Med 22(13):2113\u20132126. https:\/\/doi.org\/10.1002\/sim.1461","journal-title":"Stat Med"},{"issue":"10371","key":"1354_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0140-6736(23)00050-8","volume":"401","author":"The Lancet","year":"2023","unstructured":"The Lancet (2023) The COVID-19 pandemic in 2023: far from over. Lancet 401(10371):79. https:\/\/doi.org\/10.1016\/S0140-6736(23)00050-8","journal-title":"Lancet"},{"issue":"2","key":"1354_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/s0895-4356(99)00161-4","volume":"53","author":"A Thornton","year":"2000","unstructured":"Thornton A, Lee P (2000) Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol 53(2):207\u2013216. https:\/\/doi.org\/10.1016\/s0895-4356(99)00161-4","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1354_CR24","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1186\/s13054-020-03400-9","volume":"24","author":"J van Paassen","year":"2020","unstructured":"van Paassen J, Vos JS, Hoekstra EM, Neumann KMI, Boot PC, Arbous SM (2020) Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes. Crit Care 24(1):696. https:\/\/doi.org\/10.1186\/s13054-020-03400-9","journal-title":"Crit Care"},{"issue":"12","key":"1354_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.568789","volume":"3","author":"Z Wang","year":"2021","unstructured":"Wang Z, Chen J, Zhu C, Liu L, Qi T, Shen Y et al (2021) Thymosin Alpha-1 has no beneficial effect on restoring CD4+ and CD8+ T lymphocyte counts in COVID-19 patients. Front Immunol 3(12):568789. https:\/\/doi.org\/10.3389\/fimmu.2021.568789","journal-title":"Front Immunol"},{"key":"1354_CR26","unstructured":"World Health Organization. Weekly epidemiological update on COVID-19 - 27 April 2023. Available from: https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19---27-april-2023"},{"key":"1354_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106873","volume":"88","author":"M Wu","year":"2020","unstructured":"Wu M, Ji JJ, Zhong L, Shao ZY, Xie QF, Liu ZY et al (2020) Thymosin \u03b11 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study. Int Immunopharmacol 88:106873. https:\/\/doi.org\/10.1016\/j.intimp.2020.106873","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"1354_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.31083\/j.fbl2702048","volume":"27","author":"YH Zhang","year":"2022","unstructured":"Zhang YH, Wang WY, Pang XC, Wang Z, Wang CZ, Zhou H et al (2022) Thymosin-\u03b11 binds with ACE and downregulates the expression of ACE2 in human respiratory epithelia. Front Biosci (landmark Ed). 27(2):48. https:\/\/doi.org\/10.31083\/j.fbl2702048","journal-title":"Front Biosci (landmark Ed)."}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01354-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-023-01354-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01354-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T02:08:58Z","timestamp":1701482938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-023-01354-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1354"],"URL":"https:\/\/doi.org\/10.1007\/s10787-023-01354-2","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,16]]},"assertion":[{"value":"21 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a systematic review and meta-analysis study. The Faculty of Medicine, Pelita Harapan University Research Ethics Committee has confirmed that no ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}